Unlocking the Trillion-Dollar AI Market in Healthcare: Key Players and Trends

Strategic Insights -

The artificial intelligence revolution in the healthcare sector is accelerating at an unprecedented pace, with an estimated value of over $2.26 trillion expected by 2035. Healthcare startups are leveraging AI to multiply patients, reduce costs, and benefit investors. Key players such as Avant Technologies, Inc. (OTCQB: AVAI), Agenus Inc. (NASDAQ: AGEN), Clover Health Investments, Corp. (NASDAQ: CLOV), Zimmer Biomet Holdings, Inc. (NYSE: ZBH), and Monogram Technologies Inc. (NASDAQ: MGRM) are making significant strides in implementing AI-powered diagnostic platforms, chronic care models, and surgical robotics.

Key Takeaways:

  • Avant Technologies, Inc. (OTCQB: AVAI) and Ainnova Tech are collaborating to develop AI-powered diagnostic platforms for diabetic retinopathy and other retinal diseases, with a potential $461 billion in value unlocked by 2035.
  • Agenus Inc. (NASDAQ: AGEN) is partnering with AI biotech firm Noetik to develop predictive biomarkers for its cancer immunotherapy combo BOT/BAL, with the goal of improving clinical trial outcomes and accelerating personalized cancer care using AI-driven insights.
  • Clover Health Investments, Corp. (NASDAQ: CLOV) recently launched a new pharmacy pilot program across New Jersey in partnership with IPC's iCare+ network, enabling local pharmacies to use AI tools and real-time data to help seniors manage medications and reduce hospital visits.
  • Zimmer Biomet Holdings, Inc. (NYSE: ZBH) has entered a definitive agreement to acquire Monogram Technologies Inc. (NASDAQ: MGRM) for approximately $177 million in cash, with additional milestone-based payments up to $12.37 per share, to create the most comprehensive and flexible technology ecosystem for surgeons.
  • The global AI-in-healthcare market is expected to surpass $110 billion by 2030, with Accenture estimating that AI could unlock an additional $461 billion in value across healthcare by 2035.

Statistics:

  • Over 30% of diabetics develop diabetic retinopathy, a leading cause of preventable blindness (Source: Ainnova Tech).
  • The global AI-in-healthcare market is expected to reach $110 billion by 2030 (Source: USA News Group).
  • Accenture estimates that AI could unlock an additional $461 billion in value across healthcare by 2035 (Source: Accenture).
  • Zimmer Biomet Holdings, Inc. (NYSE: ZBH) expects the acquisition of Monogram Technologies Inc. (NASDAQ: MGRM) to be accretive by 2028, supporting long-term growth in the high-demand surgical robotics market (Source: USA News Group).

Sources:

  • USA News Group - https://usanewsgroup.com/2023/10/26/unlocking-the-trillion-dollar-ai-market-what-investors-need-to-know/
  • Accenture - (Source not explicitly provided in the original text)